Welcome to the EPA 2022 Interactive Programme
The congress will officially run on Central European Summer Time (CEST/GMT +2)
To convert the congress times to your local time Click Here
Fully Live with Live Q&A 
On Demand (available from 4 June) 
ECP Session 
Section Session 
EPA Course (Pre-Registration Required)
Ask the Expert 
Sessions with Voting 
Live TV 
Product Theatre
Session Description:
Antipsychotic dosing plays a crucial role in the long-term care of patients with schizophrenia, however, finding the optimal dose is not always straightforward. In case of cariprazine, evidence on the dosing and titration of the compound mainly comes from randomised controlled trials. Despite such trials being the gold standard, real-world evidence needs to be gathered as well in order to draw accurate conclusions on dosing. Therefore, by presenting both clinical and real-world evidence, this session aims to provide a comprehensive picture on the appropriate dosing strategies of cariprazine, including treatment initiation, switching strategies and concomitant medications.
Session Description:
Join us for what promises to be an informative and engaging session, where Dr Lila Mekaoui will share her real-world experience of using a breakthrough antidepressant in her own clinical practice at the Sainte-Anne Hospital in France. She will be joined by Professor Andrea Fagiolini from Italy, who will chair the session, and also share his experience and learnings
CP-313533 | DOP April 2022
, 